Finacea is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Intendis Inc.. The primary component is Azelaic Acid.
Product ID | 10922-825_a7594a20-f46e-4b33-91d5-410cc5e97b8d |
NDC | 10922-825 |
Product Type | Human Prescription Drug |
Proprietary Name | Finacea |
Generic Name | Azelaic Acid |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2004-12-24 |
Marketing Category | NDA / NDA |
Application Number | NDA021470 |
Labeler Name | Intendis Inc. |
Substance Name | AZELAIC ACID |
Active Ingredient Strength | 0 g/g |
Pharm Classes | Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2004-12-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021470 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2004-12-24 |
Inactivation Date | 2019-11-27 |
Ingredient | Strength |
---|---|
AZELAIC ACID | .15 g/g |
SPL SET ID: | 63773349-0295-4d56-a72e-0d7cade88ddb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10922-825 | Finacea | azelaic acid |
10922-826 | Finacea | azelaic acid |
50090-3032 | Finacea | azelaic acid |
50090-4473 | Finacea | azelaic acid |
50222-505 | Finacea | azelaic acid |
50419-825 | Finacea | azelaic acid |
0115-1624 | Azelaic Acid | Azelaic Acid |
0591-2131 | azelaic acid | azelaic acid |
51672-1389 | Azelaic Acid | Azelaic Acid |
68462-626 | azelaic acid | azelaic acid |
0781-7172 | Azelaic Acid Gel | azelaic acid |
0023-8694 | AZELEX | azelaic acid |
16110-869 | AZELEX | azelaic acid |
50222-303 | FINACEA FOAM | azelaic acid |
50419-829 | FINACEA FOAM | azelaic acid |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FINACEA 76325515 2811242 Live/Registered |
LEO PHARMA A/S 2001-10-12 |